Reportlinker Adds Molecular Diagnostics - Technologies, Markets and Companies

NEW YORK, April 4, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Molecular Diagnostics - Technologies, Markets and Companies

http://www.reportlinker.com/p0203544/Molecular-Diagnostics---Technologies-Markets-and-Companies.html

This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological warfare in the 21st century. This includes several polymerase chain reaction (PCR)-based technologies, fluorescent in situ hybridization (FISH), peptide nucleic acids (PNA), electrochemical detection of DNA, biochips, nanotechnology and proteomic technologies.

Initial applications of molecular diagnostics were mostly for infections but are now increasing in the areas of genetic disorders, preimplantation screening and cancer. Genetic screening tests, despite some restrictions is a promising area for future expansion of in vitro diagnostic market. Molecular diagnostics is being combined with therapeutics and forms an important component of integrated healthcare. Molecular diagnostic technologies are also involved in development of personalized medicine based on pharmacogenetics and pharmacogenomics. Currently, there has been a considerable interest in developing rapid diagnostic methods for point-of-care and biowarfare agents such as anthrax.

The number of companies involved in molecular diagnostics has increased remarkably during the past few years. More than 500 companies have been identified to be involved in developing molecular diagnostics and 309 of these are profiled in the report along with tabulation of 685 collaborations. Despite the strict regulation, most of the development in molecular diagnostics has taken place in the United States, which has the largest number of companies.

The markets for molecular diagnostics technologies are difficult to estimate. Molecular diagnostics markets overlap with markets for non-molecular diagnostic technologies in the in vitro diagnostic market and are less well defined than those for pharmaceuticals. Molecular diagnostic markets are analyzed for 2010 according to technologies, applications and geographical regions. Forecasts are made up to 2020. A major portion of the molecular diagnostic market can be attributed to advances in genomics and proteomics. Biochip and nanobiotechnology are expected to make a significant contribution to the growth of molecular diagnostics.

This report was first published as DNA Diagnostics in 1995 by PJB Publications, UK. It was updated in 1997 as Molecular Diagnostics and the next edition, Molecular Diagnostics II, was published by Decision Resources Inc in 1999. All the three versions of the reports were well accepted and sold widely. The report has been rewritten several times since then.

Table of contents

Part I: Technologies, Ethics & Regulations

Basics of Molecular Diagnostics

Molecular Diagnostic Technologies

Biochips, Biosensors and Molecular Labels

Proteomic Technologies for Molecular Diagnostics

Molecular Diagnosis of Genetic Disorders

Molecular Diagnosis of Infections

Molecular Diagnosis of Cancer

Molecular Diagnostics in Biopharmaceutical Industry and Healthcare

Molecular Diagnostics in Forensic Medicine and Biological Warfare

References

Part II: Markets & Companies

Ethics, Patents and Regulatory Issues

Markets for Molecular Diagnostics

Molecular Diagnostic Companies

To order this report:

: Molecular Diagnostics - Technologies, Markets and Companies

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker